EpskA21
EpskA21 is an inhibitor for PI3K/AKT signaling pathway, and inhibits the proliferation of cancer cells MCF-7, A549, MIA-PaCa-2, Panc-1 and HepG2, with IC50 of 1.3-7.24 μM. EpskA21 inhibits the cell migration, arrests the cell cycle at G2/M (MCF-7) and S (MIA-PaCa-2) phase, and induces apoptosis in MCF-7 and MIA-PaCa-2. EpskA21 causes the mitochondrial dysfunction[1].
Product Specifications
UNSPSC
12352005
Target
Akt; Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/epska21.html
Smiles
C=C1[C@H]2[C@@H](OC(/C=C/C3=CC=NC=C3)=O)[C@]4(C1=O)C([C@H]5[C@]6([H])C(C)(C)C(C=C[C@@]6(CO5)[C@]4([H])CC2)=O)=O
Molecular Formula
C28H27NO6
Molecular Weight
473.52
References & Citations
[1]Li H, et al., Design and synthesis of 6,20-epoxy A-ring modified oridonin derivatives with antitumor activity through extrinsic and mitochondrial pathways. Bioorg Chem. 2024 Jul 11;151:107632.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1306670-01 0.02 mg (E-Coli)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar copenhageni Ketol-acid reductoisomerase (ilvC)
Sign In for Pricing
View Details MBS1306670-02 0.02 mg (Yeast)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar copenhageni Ketol-acid reductoisomerase (ilvC)
Sign In for Pricing
View Details MBS1306670-03 0.1 mg (E-Coli)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar copenhageni Ketol-acid reductoisomerase (ilvC)
Sign In for Pricing
View Details MBS1306670-04 0.1 mg (Yeast)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar copenhageni Ketol-acid reductoisomerase (ilvC)
Sign In for Pricing
View Details